OpenAlex
PricingAboutJobs
Log inGet started
Work

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals

HTML

Year: 2011
Type: review
Source: Journal of Hypertension
DOI: 10.1097/hjh.0b013e328344a7de
Author: The ARB Trialists Collaboration
Institutions: Hamilton General Hospital, Population Health Research Institute
Language: English

Topic: Renin-Angiotensin System Studies
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: angiotensin receptor blockers, ACE inhibitors, cancer incidence, telmisartan, irbesartan, valsartan, candesartan, losartan, drug safety, cardiovascular disease, combination therapy, antihypertensive drugs, cancer risk
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W108690756
FWCI: 4.172
Cites: 41
Cited by: 208
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms